How Much Does Immunotherapy Cost in Austria?
The cost of immunotherapy in Austria typically ranges from $9,000 to $19,000. Pricing can vary depending on the type of immunotherapy (such as checkpoint inhibitors, CAR T-cell therapy, or monoclonal antibodies), the specific medication, the number of treatment cycles, and the clinic’s location. In the United States, the average cost is $28,500 (according to the American Cancer Society). Immunotherapy in Austria is generally about 51% less expensive than in the U.S.
In Austria, immunotherapy packages usually include medical consultations, treatment planning, drug administration, monitoring, and follow-up visits. Hospitalization, lab tests, and imaging may be included for some protocols. In the U.S., drug costs, infusions, and supportive care are often billed separately, and insurance coverage varies. Always confirm exactly what’s included with your chosen Austrian clinic.
| Turkey | Austria | Spain | |
|---|---|---|---|
| Immunotherapy | from $2,500 | ≈ $9,000 | from $3,500 |
| Sarcoma Immunotherapy | from $8,900 | ≈ $18,000 | from $6,000 |
| Immunotherapy with Keytruda (Pembolizumab) | from $2,800 | ≈ $5,800 | from $13,500 |
| Immunotherapy for prostate cancer | from $8,000 | ≈ $9,500 | from $6,000 |
| Immunotherapy for lung cancer | from $8,000 | ≈ $5,800 | from $5,000 |
Your Benefits and Guarantees with Bookimed
Transparent Prices & Flexible Installments
No hidden fees – just official clinic prices. Pay at the clinic for Immunotherapy upon arrival and use a flexible installment plan if needed.
Verified Clinics & Doctors Only
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Immunotherapy and have the necessary licenses to serve international patients worldwide.
Free 24/7 Assistance
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Immunotherapy journey.

Your personal Bookimed medical coordinator
- Supports you at every stage
- Helps choose the right clinic and doctor
- Ensures quick and convenient access to information
Discover the Best Immunotherapy Clinics in Austria: 3 Verified Options and Prices
Wiener Privatklinik (WPK)
Christoph Zielinski










pansatori GmbH
Immunotherapy in Austria: Your Travel Plan
Day 1: Arrival in Austria
- Upon arrival, you should have all necessary documents, including your passport, visa (if required), and any medical records related to your condition.
- Check into your pre-arranged accommodation. You need to rest and acclimatize to the new environment.
- Contact your assigned coordinator via phone or email to confirm the schedule for your initial consultation and diagnostics. This step is crucial to avoid misunderstandings about your appointment times.
- Prepare a list of questions or concerns to discuss with your medical team. Include inquiries about the immunotherapy process, potential side effects, and expected outcomes.
Day 2: Initial Consultation and Diagnostics
- Attend your initial consultation at the clinic. You will undergo a thorough review of your medical history and any prior treatments.
- Undergo necessary diagnostics, which may include blood tests, imaging studies, or biopsies. These tests are essential to tailor the immunotherapy to your specific needs.
- Discuss the results of your diagnostics with your medical team. Based on these results, they will propose a personalized treatment plan.
- Sign any required consent forms after understanding the details of the proposed treatment, including the use of specific medications like Keytruda (pembrolizumab).
Day 3: Preparation for Immunotherapy
- Receive detailed instructions on how to prepare for your immunotherapy session. This may include dietary recommendations or restrictions on certain medications.
- Ensure you have arranged transportation to and from the clinic for your treatment sessions. It's advisable to have a companion with you for support.
- Stay hydrated and maintain a balanced diet to ensure your body is in optimal condition for treatment.
- Get plenty of rest the night before your treatment to help your body cope with the therapy.
Day 4: Immunotherapy Session
- Arrive at the clinic at the scheduled time for your immunotherapy session. Punctuality is important to maintain the treatment schedule.
- The medical team will administer the immunotherapy, such as Keytruda, via intravenous infusion. The process may take several hours, so bring reading material or music for comfort.
- Monitor for any immediate side effects under the supervision of healthcare professionals. Common side effects may include fatigue, fever, or nausea.
- After the session, you will be observed for a short period to ensure there are no adverse reactions before being discharged.
Day 5: Post-Treatment Care
- Follow any post-treatment care instructions provided by your medical team. This may include medications to manage side effects or dietary guidelines.
- Attend any scheduled follow-up appointments to monitor your progress and adjust the treatment plan as necessary.
- Maintain open communication with your coordinator and medical team. Report any unusual symptoms or concerns immediately.
- Engage in light activities and avoid strenuous exercise until you receive clearance from your healthcare provider.
Day 6-7: Rest and Recovery
- Use these days to rest and allow your body to recover from the treatment. Listen to your body's signals and avoid overexertion.
- Continue to hydrate and eat nutritious meals to support your immune system.
- Reflect on your treatment experience and prepare any additional questions for your healthcare team during your next visit.
- If you experience persistent side effects, contact the clinic for advice on managing them effectively.
Day 8: Follow-Up and Departure Preparation
- Attend a follow-up appointment to assess your response to the immunotherapy. This may include additional tests or consultations.
- Discuss the next steps in your treatment plan, including any future immunotherapy sessions or complementary therapies.
- Make arrangements for your departure, ensuring you have all necessary documentation and prescriptions for medications you may need at home.
- Provide feedback to the clinic about your experience, which can be valuable for improving patient care and services.
Day 9: Departure from Austria
- Check out of your accommodation and ensure all personal belongings are packed.
- Travel to the airport with ample time before your
Bookimed, a leading global medical tourism platform, is committed to helping clients looking for Immunotherapy in Austria by offering expert assistance and trustworthy medical solutions for every situation. Smart automatic ranking system is used to compose transparent clinic listings, meticulously maintained by a data scientist using AI for accuracy. The platform guarantees authenticity by publishing reviews from real patients after their treatments. Bookimed offers comprehensive medical solutions, with updates from clinics to ensure trustworthiness. The content about Immunotherapy in Austria, crafted by experienced medical authors and reviewed by specialists, adheres to Bookimed"s Editorial Guidelines, reflecting the platform"s commitment to delivering high-quality and clear health information. For more details or inquiries, feel free to contact us at marketing@bookimed.com or learn more about us and our mission About Bookimed .
Our Doctors
View all Doctors
Christoph Zielinski
Prof. Christoph Zielinski is a global leader in immunotherapy with 44 years shaping modern cancer care. He integrates cutting-edge research with personalized patient treatments.
- Founded Vienna's Comprehensive Cancer Center (CCC) – unifying research and clinical care
- Headed Austria's largest oncology department at Vienna General Hospital
- Former President of the Central European Cooperative Oncology Group (CECOG)
- Specializes in tumor biology-driven individualized cancer therapies

Wolfgang Köstler
Univ. Prof. Dr. Wolfgang Köstler is a leading expert in breast cancer and gynecologic malignancies, with over 22 years of experience in targeted cancer therapies at Wiener Privatklinik.
- Specializes in solid tumor oncology, focusing on breast and gynecologic cancers
- Deputy Head of the Clinical Division of Oncology at Medical University of Vienna
- Active in translational research and biomarker development for precision oncology
- Published extensively in leading international journals on tumor biology

Alexander Hauswirth
Assoc. Prof. Priv.-Doz. Dr. Alexander W. Hauswirth is a specialist in internal medicine and haemato‑oncology at JUVENIS. Since 2010, he has served as the lead senior physician for Haematology/Haemostaseology and Oncology at the Clinic for Internal Medicine I, Medical University of Vienna/AKH Vienna, Austria’s largest hospital.
He earned his medical degree from the University of Vienna in 1999. He received the venia docendi in 2010 and was appointed Associate Professor in 2012. He completed an additional haemato‑oncology qualification in 2014. As a Schrödinger Fellow in Salamanca in 2009–2010, he researched CLL stem and precursor cells. He has published regularly since 2000.
Accreditations include Austrian Medical Chamber diplomas in emergency medicine (since 2009) and sports medicine (2018). Awards include the Schrödinger Fellowship (2009), the ÖGHO award (2009), and the European Society of Chemotherapy poster award (2003). Clinical focus: anaemias, leukaemias, lymph node disorders, clotting and anticoagulation, and pre‑operative clearance. Languages: German and English.
Video Stories from Bookimed Patients
Reviews about Bookimed: Discover Patients' Insights
All reviewsRelated Articles

Immunotherapy for Cancer Cost: Global Comparison 2026
Written by Kateryna Zamkovska
Share this content
Clinical research summaries
Published research with its context and limitations.
All research summaries →
Anna Leonova
Our Immunotherapy Techniques: What Suits You Best?
When considering Immunotherapy, it’s important to understand the different techniques and which is best suited for you. Here’s a concise comparison of popular options:

Immunotherapy with Keytruda (Pembolizumab)
Keytruda, a form of immune-based therapy, leverages the body's immune system to target and destroy cancer cells using monoclonal antibodies.
FAQ about Immunotherapy in Austria
What is immunotherapy and how is it applied in Austria?
Immunotherapy is a precision treatment that trains the immune system to identify and destroy cancer cells or manage severe allergies. In Austria, clinics apply this via checkpoint inhibitors, monoclonal antibodies, and targeted desensitization protocols, often integrating molecular genetic profiling to ensure therapy matches the specific tumor biology.
- Treatment methods: Use of checkpoint inhibitors like Keytruda or targeted cellular therapies for oncology.
- Diagnostic precision: Clinics employ AI-assisted diagnostics and PET/CT staging for personalized treatment planning.
- Clinical expertise: Facilities like Wiener Privatklinik are led by experts like Professor Christoph Zielinski.
- Therapeutic range: Covers diverse conditions including lung cancer, melanoma, and long-term allergy desensitization.
Bookimed Expert Insight: Austria stands out for its high concentration of academic leadership within private settings. For example, the Confraternitaet & Goldenes Kreuz is staffed by Medical University of Vienna professors. This provides patients with direct access to research-level protocols, such as biomarker-driven oncology, without the typical wait times found in public university hospitals.
Patient Consensus: Patients value the high level of specialist coordination but emphasize that allergy immunotherapy is a long-term commitment. Those undergoing cancer treatment stress the importance of monitoring organ function, specifically regarding thyroid and liver health, during the protocol.
Who are the notable specialists leading immunotherapy research and treatment in Austria?
Austria features leading immunotherapy specialists like Prof. Dr. Christoph Zielinski and Univ.-Prof. Dr. Wolfgang Kostler at Wiener Privatklinik. These experts drive global advancements in personalized oncology, utilizing precision medicine, biomarker development, and clinical trials at institutions like the Medical University of Vienna to treat complex malignancies.
- Prof. Christoph Zielinski: Chairman of Vienna Cancer Center specializes in personalized systemic therapy and tumor biology.
- Dr. Wolfgang Kostler: Expert at Wiener Privatklinik focused on targeted therapy for solid tumors and sarcomas.
- Univ.-Prof. Richard Greil: Directs Salzburg Cancer Research Institute, leading clinical trials for hematological and solid tumors.
- Dr. Matthias Preusser: Leads neuro-oncology research at Vienna General Hospital, focusing on brain tumor immunotherapeutic protocols.
Bookimed Expert Insight: While specialists like Dr. Zielinski and Dr. Kostler practice at top-tier private clinics, they simultaneously hold senior positions at the Medical University of Vienna. This dual affiliation ensures patients access academic-level research and experimental biomarker testing within a more efficient, private hospital setting like Wiener Privatklinik.
Patient Consensus: Patients value the multidisciplinary approach found in Vienna, noting that top specialists provide clear communication and significantly shorter wait times compared to other European hubs. Many emphasize the importance of choosing doctors embedded in major research networks for the latest targeted drug options.
Are international patients eligible to receive immunotherapy in Austrian private clinics?
International patients are fully eligible for immunotherapy in Austrian private clinics, particularly in Vienna. Premier institutions like Wiener Privatklinik and Confraternität provide advanced checkpoint inhibitors and personalized systemic therapies. Access depends on clinical evaluation of pathology reports, imaging, and treatment history by multidisciplinary tumor boards.
- Available therapies: Includes Keytruda (Pembrolizumab), targeted biological therapies, and Bacillus Calmette-Guérin (BCG) treatment.
- Specialized centers: Clinics often feature dedicated International Oncology Centers with ISO 9001 quality management.
- Expert access: Patients consult with professors from the Medical University of Vienna specializing in molecular oncology.
- International support: Facilities coordinate medical visa documentation, language interpretation, and translation of complex medical records.
Bookimed Expert Insight: While 40% of patients at clinics like Wiener Privatklinik come from abroad, eligibility is strictly case-by-case. Success depends on the specific tumor biology rather than just the cancer stage. Data shows that clinics with high international volumes, such as those serving over 12,000 patients annually, have more streamlined logistics for remote second opinions before travel.
Patient Consensus: Patients emphasize the high quality of doctors and staff, often recommending these facilities to others. Many advise framing initial inquiries as oncology consultations to ensure a comprehensive clinical evaluation of treatment history.
Which top medical centers and clinics in Austria offer immunotherapy?
Austria features world-class medical centers specializing in advanced immunotherapy, including Wiener Privatklinik and Confraternitaet Private Clinic. These facilities utilize personalized tumor profiling and checkpoint inhibitors, like Keytruda, administered by oncology experts from the Medical University of Vienna to treat lung, breast, and prostate cancers.
- Top private facility: Wiener Privatklinik holds Newsweek World Best Hospital rankings and ISO 9001 certification.
- Leading oncology expert: Prof. Christoph Zielinski at WPK is a pioneer in personalized immuno-oncology.
- Academic collaboration: Confraternitaet Private Clinic utilizes university professors for complex targeted biological therapy.
- Treatment range: Facilities offer specialized protocols including BCG therapy and individualized systemic cancer treatments.
Bookimed Expert Insight: Wiener Privatklinik manages a high international volume, with 40% of patients traveling from abroad. This global demand stems from their 95% positive outcome rate and access to prominent researchers like Dr. Wolfgang Köstler. For patients, this means faster access to university-level expertise without the long wait times typical of public systems.
Patient Consensus: Patients value these centers for high-level second opinions and expert staff. Many note that accessing private practices of university-affiliated doctors is the fastest way to secure specialized cancer consultations.



